DBV Technologies | DBVT - القيمة السوقية





القيمة السوقية تغيير تاريخ
Acadia Pharmaceuticals USD 3.8B 724M 2026-03
Alnylam Pharmaceuticals USD 44.15B 8.39B 2026-03
Amarin USD 290M 51M 2025-12
BioCryst Pharmaceuticals USD 1.66B 64M 2025-12
BioMarin Pharmaceutical USD 10.86B 553M 2026-03
DBV Technologies USD 274M 17M 2025-09
Esperion Therapeutics USD 885M 351M 2025-12
Halozyme Therapeutics USD 7.66B 257M 2026-03
Incyte USD 18.73B 660M 2026-03
Insmed USD 35.3B 1.82B 2026-03
Ionis Pharmaceuticals USD 12.46B 356M 2026-03
Neurocrine Biosciences USD 13.25B 890M 2026-03
PTC Therapeutics USD 5.64B 460M 2026-03
Sarepta Therapeutics USD 2.28B 30M 2026-03
Ultragenyx Pharmaceutical USD 2.06B 159M 2026-03
United Therapeutics USD 25.19B 4.21B 2026-03